{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:04:34Z","timestamp":1792681474730,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bcp.2024.116561","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T17:24:11Z","timestamp":1727457851000},"page":"116561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P1","title":["Aspirin increases estrogen levels in the placenta to prevent preeclampsia by regulating placental metabolism and transport function"],"prefix":"10.1016","volume":"230","author":[{"given":"Shengbo","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenmeizi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangcai","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2024.116561_b0005","doi-asserted-by":"crossref","unstructured":"M.A. Brown, L.A. Magee, L.C. Kenny, S.A. Karumanchi, F.P. McCarthy, S. Saito, D.R. Hall, C.E. Warren, G. Adoyi, S. Ishaku, P. International Society for the Study of Hypertension in, Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice, Hypertension 72(1) (2018) 24-43.","DOI":"10.1161\/HYPERTENSIONAHA.117.10803"},{"issue":"3","key":"10.1016\/j.bcp.2024.116561_b0010","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ajog.2017.04.032","article-title":"Short-term costs of preeclampsia to the United States health care system","volume":"217","author":"Stevens","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.bcp.2024.116561_b0015","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"ACOG Practice Bulletin, Number 222","volume":"135","author":"Gestational Hypertension and Preeclampsia","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bcp.2024.116561_b0020","doi-asserted-by":"crossref","first-page":"S844","DOI":"10.1016\/j.ajog.2021.11.1356","article-title":"The etiology of preeclampsia","volume":"226","author":"Jung","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bcp.2024.116561_b0025","doi-asserted-by":"crossref","first-page":"S786","DOI":"10.1016\/j.ajog.2021.12.001","article-title":"Preeclampsia and eclampsia: the conceptual evolution of a syndrome","volume":"226","author":"Erez","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"14","key":"10.1016\/j.bcp.2024.116561_b0030","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jacc.2020.08.014","article-title":"Preeclampsia-Pathophysiology and Clinical Presentations: State-of-the-Art Review","volume":"76","author":"Ives","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.bcp.2024.116561_b0035","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.2215\/CJN.12081115","article-title":"Preeclampsia: Updates in Pathogenesis","volume":"11","author":"Phipps","year":"2016","journal-title":"Definitions, and Guidelines, Clin J Am Soc Nephro"},{"issue":"5","key":"10.1016\/j.bcp.2024.116561_b0040","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s40265-023-01842-3","article-title":"Aspirin for the Prevention of Early and Severe Pre-Eclampsia Recurrence: A Real-World Population-Based Study","volume":"83","author":"Lailler","year":"2023","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.bcp.2024.116561_b0045","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ajog.2022.10.014","article-title":"Comparative effectiveness of prophylactic strategies for preeclampsia: a network meta-analysis of randomized controlled trials","volume":"228","author":"Liu","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bcp.2024.116561_b0050","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bcp.2024.116561_b0055","doi-asserted-by":"crossref","first-page":"S1157","DOI":"10.1016\/j.ajog.2020.09.014","article-title":"Pravastatin, proton-pump inhibitors, metformin, micronutrients, and biologics: new horizons for the prevention or treatment of preeclampsia","volume":"226","author":"Tong","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bcp.2024.116561_b0060","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive Disorders of Pregnancy ISSHP Classification, Diagnosis, and Management Recommendations for International Practice","volume":"72","author":"Brown","year":"2018","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.bcp.2024.116561_b0065","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/01.AOG.0000437382.03963.88","article-title":"Hypertension in Pregnancy","volume":"122","author":"Roberts","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bcp.2024.116561_b0070","unstructured":"World Health Organization. Cardiovascular diseases (CVDs): key facts. 2017. https:\/\/www.who.int\/news-room\/fact-sheets."},{"issue":"1","key":"10.1016\/j.bcp.2024.116561_b0075","doi-asserted-by":"crossref","first-page":"95.e1","DOI":"10.1016\/j.ajog.2020.07.023","article-title":"Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study","volume":"224","author":"Hastie","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bcp.2024.116561_b0080","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/978-981-13-7647-4_11","article-title":"Contributions of Drug Transporters to Blood-Placental Barrier","volume":"1141","author":"Liu","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.bcp.2024.116561_b0085","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.apsb.2019.11.016","article-title":"New insights of CYP1A in endogenous metabolism: a focus on single nucleotide polymorphisms and diseases","volume":"10","author":"Lu","year":"2020","journal-title":"Acta Pharmacol Sin B"},{"issue":"2","key":"10.1016\/j.bcp.2024.116561_b0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/03602532.2015.1011658","article-title":"Regioselective hydroxylation of steroid hormones by human cytochromes P450","volume":"47","author":"Niwa","year":"2015","journal-title":"Drug Metab Rev"},{"issue":"4","key":"10.1016\/j.bcp.2024.116561_b0095","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/17512433.2018.1425615","article-title":"The role of the placenta in drug transport and fetal drug exposure","volume":"11","author":"Koren","year":"2018","journal-title":"Expert Rev Clin Phar"},{"issue":"7","key":"10.1016\/j.bcp.2024.116561_b0100","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1124\/dmd.114.062315","article-title":"Polyinosinic\/Polycytidylic Acid-Mediated Changes in Maternal and Fetal Disposition of Lopinavir in Rats","volume":"43","author":"Petrovic","year":"2015","journal-title":"Drug Metab Dispos"},{"issue":"14","key":"10.1016\/j.bcp.2024.116561_b0105","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1097\/QAD.0000000000003009","article-title":"Impact of in-utero antiretroviral drug exposure on expression of membrane-associated transporters in mouse placenta and fetal brain","volume":"35","author":"Gilmore","year":"2021","journal-title":"Aids"},{"key":"10.1016\/j.bcp.2024.116561_b0110","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.fct.2019.03.043","article-title":"Food components and environmental chemicals of inhibiting human placental aromatase","volume":"128","author":"Wang","year":"2019","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.bcp.2024.116561_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2023.107763","article-title":"Placental transcriptomic signatures of prenatal exposure to Hydroxy-Polycyclic aromatic hydrocarbons","volume":"172","author":"Paquette","year":"2023","journal-title":"Environ Int"},{"key":"10.1016\/j.bcp.2024.116561_b0120","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.placenta.2020.07.012","article-title":"The impact of intrauterine growth restriction on cytochrome P450 enzyme expression and activity","volume":"99","author":"McBride","year":"2020","journal-title":"Placenta"},{"issue":"1","key":"10.1016\/j.bcp.2024.116561_b0125","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1542\/peds.111.1.e77","article-title":"Low-dose aspirin in pregnancy: Maternal and neonatal aspirin concentrations and neonatal prostanoid formation","volume":"111","author":"Leonhardt","year":"2003","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.bcp.2024.116561_b0130","doi-asserted-by":"crossref","first-page":"e218401","DOI":"10.1001\/jamanetworkopen.2021.8401","article-title":"Preeclampsia Prevalence, Risk Factors, and Pregnancy Outcomes in Sweden and China","volume":"4","author":"Yang","year":"2021","journal-title":"Jama Network Open"},{"issue":"2","key":"10.1016\/j.bcp.2024.116561_b0135","doi-asserted-by":"crossref","first-page":"251.e1","DOI":"10.1016\/j.ajog.2021.08.004","article-title":"A randomized controlled trial of low-dose aspirin for the prevention of preeclampsia in women at high risk in China","volume":"226","author":"Lin","year":"2022","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.bcp.2024.116561_b0140","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.toxlet.2020.02.014","article-title":"Activities of metabolizing enzymes in human placenta","volume":"326","author":"Mohammed","year":"2020","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.bcp.2024.116561_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115457","article-title":"Establishment of LC-MS\/MS method for quantifying chlorpromazine metabolites with application to its metabolism in liver and placenta microsomes","volume":"233","author":"Fu","year":"2023","journal-title":"J Pharmaceut Biomed"},{"key":"10.1016\/j.bcp.2024.116561_b0150","article-title":"Differential proteomics analysis of JEG-3 and JAR placental cell models and the effect of androgen treatment","volume":"222","author":"Kruger","year":"2022","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.bcp.2024.116561_b0155","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.toxlet.2018.07.021","article-title":"Design and optimization of the cocktail assay for rapid assessment of the activity of UGT enzymes in human and rat liver microsomes","volume":"295","author":"Chen","year":"2018","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.bcp.2024.116561_b0160","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.toxlet.2017.09.014","article-title":"Assessment of the inhibition risk of shikonin on cytochrome P450 via cocktail inhibition assay","volume":"281","author":"Tang","year":"2017","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.bcp.2024.116561_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104637","article-title":"Assessment of the inhibition risk of paris saponins, bioactive compounds from, on CYP and UGT enzymes via cocktail inhibition assays","volume":"113","author":"Luo","year":"2020","journal-title":"Regul Toxicol Pharm"},{"issue":"9","key":"10.1016\/j.bcp.2024.116561_b0170","first-page":"1027","article-title":"Physiology and Pathophysiology of Steroid Biosynthesis","volume":"12","author":"Chatuphonprasert","year":"2018","journal-title":"Transport and Metabolism in the Human Placenta, Front Pharmacol"},{"issue":"11","key":"10.1016\/j.bcp.2024.116561_b0175","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/s41440-022-01002-2","article-title":"Estrogen normalizes maternal HFD-induced vascular dysfunction in offspring by regulating ATR","volume":"45","author":"Chen","year":"2022","journal-title":"Hypertens Res"},{"issue":"2\u20133","key":"10.1016\/j.bcp.2024.116561_b0180","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1387\/ijdb.082758ea","article-title":"Estrogen regulation of placental angiogenesis and fetal ovarian development during primate pregnancy","volume":"54","author":"Albrecht","year":"2010","journal-title":"Int J Dev Biol"},{"issue":"4","key":"10.1016\/j.bcp.2024.116561_b0185","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/humupd\/dmu008","article-title":"Androgens in pregnancy: roles in parturition","volume":"20","author":"Makieva","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bcp.2024.116561_b0190","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.2147\/DDDT.S304316","article-title":"Estrogen and Preeclampsia: Potential of Estrogens as Therapeutic Agents in Preeclampsia","volume":"15","author":"Shu","year":"2021","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.bcp.2024.116561_b0195","doi-asserted-by":"crossref","first-page":"gaab013","DOI":"10.1093\/molehr\/gaab013","article-title":"Downregulation of aromatase plays a dual role in preeclampsia","author":"Zhu","year":"2021","journal-title":"Mol Hum Reprod 27(4)"},{"issue":"2","key":"10.1016\/j.bcp.2024.116561_b0200","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1210\/er.2016-1065","article-title":"From Pregnancy to Preeclampsia: A Key Role for Estrogens","volume":"38","author":"Berkane","year":"2017","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.bcp.2024.116561_b0205","first-page":"E390","article-title":"Characterization and identification of steroid sulfate transporters of human placenta","volume":"284","author":"Ugele","year":"2003","journal-title":"Am J Physiol-Endoc M"},{"key":"10.1016\/j.bcp.2024.116561_b0210","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bcp.2016.12.020","article-title":"A novel mode of operation of SLC22A11: Membrane insertion of estrone sulfate versus translocation of uric acid and glutamate","volume":"128","author":"Skwara","year":"2017","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.bcp.2024.116561_b0215","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11095-006-9181-4","article-title":"Organic anion transporters of the SLC22 family: Biopharmaceutical, physiological, and pathological roles","volume":"24","author":"Rizwan","year":"2007","journal-title":"Pharm Res-Dordr"},{"issue":"25","key":"10.1016\/j.bcp.2024.116561_b0220","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1161\/CIRCULATIONAHA.112.127340","article-title":"Cytochrome P450 Subfamily 2J Polypeptide 2 Expression and Circulating Epoxyeicosatrienoic Metabolites in Preeclampsia","volume":"126","author":"Herse","year":"2012","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.bcp.2024.116561_b0225","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/HJH.0000000000000942","article-title":"Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta","volume":"34","author":"Vedove","year":"2016","journal-title":"J Hypertens"},{"issue":"6","key":"10.1016\/j.bcp.2024.116561_b0230","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.acthis.2018.06.002","article-title":"Time-dependent expression pattern of cytochrome P450 epoxygenases and soluble epoxide hydrolase in normal human placenta","volume":"120","author":"Cizkova","year":"2018","journal-title":"Acta Histochem"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224005616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224005616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T22:02:35Z","timestamp":1732831355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224005616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":46,"alternative-id":["S0006295224005616"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116561","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin increases estrogen levels in the placenta to prevent preeclampsia by regulating placental metabolism and transport function","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116561","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116561"}}